Driving innovation in life sciences: What is next for developing breakthrough therapies?
Life Sciences & Health Care
September 19 | 1 p.m. ET | 17:00 GMT
Host: Terry Hisey, principal, Deloitte Consulting LLP
1 Overview CPE credit | Specialized Knowledge & Applications
New innovations could dramatically change health care, especially relating to chronic and life-threatening conditions. How can biopharma and medtech companies leverage such innovations to advance breakthrough therapies and provide better patient-centered care? We'll discuss:
- Technologies and analytics that improve care quality in therapeutic areas such as oncology, diabetes, and cardiovascular by enabling patient access to cutting-edge treatments and clinical trials while reducing disparities in care.
- New operating models based on end-to-end evidence management and real-world evidence (RWE) that help deliver value and drive innovation.
- The importance of cross-industry collaboration in bringing new products and therapies to market.
Learn about Deloitte's RWE Benchmark Survey and how organizations can effectively move toward patient-centered care.